| CTRI Number |
CTRI/2024/11/077350 [Registered on: 26/11/2024] Trial Registered Prospectively |
| Last Modified On: |
19/10/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Observational |
|
Type of Study
|
Follow Up Study |
| Study Design |
Other |
|
Public Title of Study
|
Neck pain in head and neck cancer patients |
|
Scientific Title of Study
|
Evaluation of Neck Pain and Related Issues in Head and Neck Cancer Patients Receiving Anti-cancer Treatment: A Follow-Up Study |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Abhishek Daf |
| Designation |
Post Graduate Student |
| Affiliation |
Department of Oncology Physiotherapy, KAHER Institute of Physiotherapy |
| Address |
KAHER Institute of Physiotherapy, Department of Oncology Physiotherapy, OPD Number 39, Room Number 29, Nehru Nagar, Belgaum- 590010, Karnataka, India.
Belgaum KARNATAKA 590010 India |
| Phone |
8999485908 |
| Fax |
|
| Email |
daaffabhishek@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Nikita Pawar |
| Designation |
Assistant professor |
| Affiliation |
KAHER Institute of Physiotherapy, Department of Oncology Physiotherapy, Belgaum, Karnataka. |
| Address |
KAHER Institute of Physiotherapy, Department of Oncology Physiotherapy, OPD Number 39, Room Number 29, Nehru Nagar, Belgaum, Karnataka.
Belgaum KARNATAKA 590010 India |
| Phone |
9731012979 |
| Fax |
|
| Email |
nikitapawar@klekipt.edu.in |
|
Details of Contact Person Public Query
|
| Name |
Nikita Pawar |
| Designation |
Assistant professor |
| Affiliation |
KAHER Institute of Physiotherapy, Department of Oncology Physiotherapy, Belgaum, Karnataka. |
| Address |
KAHER Institute of Physiotherapy, Department of Oncology Physiotherapy, OPD Number 39, Room Number 29, Nehru Nagar, Belgaum, Karnataka.
Belgaum KARNATAKA 590010 India |
| Phone |
9731012979 |
| Fax |
|
| Email |
nikitapawar@klekipt.edu.in |
|
|
Source of Monetary or Material Support
|
| KLE Academy of Higher Education and Research, Belgaum-590010, Karnataka, India |
|
|
Primary Sponsor
|
| Name |
KLE Academy of Higher Education and Research |
| Address |
KAHER Institute of Physiotherapy, Department of Oncology Physiotherapy, OPD Number 39, Room Number 29, Nehru Nagar, Belgaum, Karnataka. |
| Type of Sponsor |
Private medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Nikita Pawar |
KLEs Dr Prabhakar Kore Hospital and Medical Research Center |
KAHER Institute Of Physiotherapy, Department of Oncology Physiotherapy, OPD Number 39, Room Number 29, Belgaum, Karnataka. Belgaum KARNATAKA |
9731012979
nikitapawar@klelipt.edu.in |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| KLE ACADEMY OF HIGHER EDUCATION AND RESEARCH |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: C148||Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
NIL |
NIL |
| Comparator Agent |
NIL |
NIL |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
85.00 Year(s) |
| Gender |
Both |
| Details |
1. Diagnosed head and neck cancer patients
2. Both male and female patients above 18 years of age.
3. Patients undergoing surgery for head and neck cancer
4. Patients undergoing radiation therapy or chemotherapy.
|
|
| ExclusionCriteria |
| Details |
1. Patients not willing to participate
2. Metastasis to other sites
3. Diagnosis other than head and neck cancer
4.cognitive impairment, or psychiatric disorders
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Neck pain |
baseline, 1st month, 2nd month, and 3rd month |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| neck disability, anxiety and depression, quality of life |
baseline, 1st month, 2nd month, and 3rd month |
|
|
Target Sample Size
|
Total Sample Size="35" Sample Size from India="35"
Final Enrollment numbers achieved (Total)= "36"
Final Enrollment numbers achieved (India)="36" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
05/11/2025 |
| Date of Study Completion (India) |
10/04/2025 |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Date Missing |
|
Estimated Duration of Trial
|
Years="0" Months="10" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Completed |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Aim: To assess neck pain and related concerns in head and neck cancer patients receiving anti-cancer treatment.
Research question: What is the severity of neck pain and related concerns and how does it vary during anti-cancer treatment among head and neck cancer (HNC) patients? Inclusion criteria: 1. Diagnosed head and neck cancer patients 2.Both male and female patients above 18 years of age 3.Patients undergoing surgery for head and neck cancer 4. Patients undergoing radiation therapy or chemotherapy. Exclusion criteria: 1. Patients not willing to participate 2.Metastasis to other sites 3. Diagnosis other than head and neck cancer. 4. Cognitive impairment or psychiatric disorders. A written informed consent for participation in the study will be obtained from all the patients. All the willing patients will be screened for inclusion and exclusion criteria. Patients meeting the eligibility criteria will undergo baseline evaluation using PAIN-DETECT, FACT-H&N, Neck Disability Index, and HADS 2 to 3 days before the initiation of treatment for cancer. Then the regular follow-up assessments will be conducted at predefined intervals at the end of 1st month, 2nd month, and 3rd month. After the collection of data statistical analysis will be done. |